Minimum effective sodium valproate dose in genetic generalized epilepsies
Author:
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,General Medicine
Reference29 articles.
1. ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by ILAE Task Force on Nosology and Definitions;Hirsch;Epilepsia,2022
2. SANAD Study group. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for treatment of generalised and unclassifiable epilepsy: an unblinded randomized controlled trial;Marson;Lancet,2007
3. SANAD II collaborators. The SANAD II study of effectiveness of valproate or levetiracetam in generalised and unclassifiable epilepsy: an un-blinded randomised controlled trial;Marson;Lancet,2021
4. Childhood Absence Epilepsy Study Team. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months;Glauser;Epilepsia,2013
5. Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors;Stevelink;Eur J Neurol,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Machine Learning Applications for Drug Repurposing;Artificial Intelligence and Machine Learning in Drug Design and Development;2024-06-19
2. Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication;Neurology;2024-05
3. A patient-centered equilibrium strategy for selecting anti-epileptic drugs in juvenile myoclonic epilepsy management;Journal of Industrial and Management Optimization;2024
4. Imperatorin interacts additively with novel antiseizure medications in the mouse maximal electroshock-induced seizure model: an isobolographic transformation;Pharmacological Reports;2023-11-28
5. Equity in access to antiseizure medications: Who has the right to decide and what are the consequences of crisis decisions?;Epilepsia;2023-06-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3